Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in Madison. As part of our effort to raise ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

“We remain on track for phase 2b and phase 3 topline data in non-metastatic, localized prostate cancer for CAN-2409 in the fourth quarter of 2024, and hope we will deliver the data and regulatory ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Investigators conducted a trial of MRI as a screening tool to reduce overdetection of insignificant prostate cancer.

She gets me through the day," says Hartter. So the reason a 73-year-old man with stage 4 cancer gets up and rides most days ...

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new s ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...